340B INDUSTRY LEADER SPOTLIGHT

Abby Kleczynski, Manager Strategic Accounts, The Craneware Group

Abby Kleczynski

Q: Where did you grow up?

Blandon, PA

Q: Where did you go to college/graduate school?

Undergrad: Temple University, Philadelphia, PA

Pharmacy: Temple University School of Pharmacy, Philadelphia,

Read More »

Expert Tip From AuthorityRx

img
img

TIP: Build your 340B Rolodex to make your 340B experience easier to navigate.


Throughout any 340B stakeholder’s

Read More »

Federal Court Grants Texas Hospitals’ Request to Temporarily Block DSH Calculation Changes

A federal court sided with a group of Texas hospitals’ efforts to block an HHS rule.
A federal court last week sided with a group of Texas hospitals’ efforts to block—at least temporarily—a Department of Health [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

The Demise of Chevron Deference – What Does It Mean for the 340B Program?

SPONSORED CONTENT

The Supreme Court recently upended a cornerstone of administrative law, known as “Chevron deference,” in Loper Bright Enterprises v. Raimondo. A major question for 340B stakeholders is how the Loper decision will impact the 340B program. 

Although the Loper decision overturned 40 years

Read More »

AHA Raises ‘Serious Concerns’ with MedPAC’s Direction on 340B

American Hospital Association logo
AHA officials penned a Medical Economics op-ed on “the truth behind growth of the 340B prescription drug program.”
A major hospital advocacy group recently urged congressional advisers to “carefully consider” the potential negative consequences of any new efforts [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Organon Partially Exempts Missouri, Minnesota Providers from 340B Contract Pharmacy Restrictions

Organon partially exempted covered entities in two states from its contract pharmacy restrictions.
Organon, a spinoff of pharmaceutical giant Merck with a focus on women’s health, has partially exempted covered entities in Missouri [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

GSK Announces Refunds for 340B Overcharges

GlaxoSmithKline will refund covered entities that purchased certain formulations of a severe asthma treatment in 2022.
GlaxoSmithKline (GSK) will refund covered entities that purchased certain formulations of a severe asthma treatment medication in the third quarter [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

340B ESP Updates Claims Submission Policy, Stakeholders Voice Concerns About Compliance

Second Sight Solutions updated 340B ESP's terms of use on Oct. 4.
340B covered entities could soon be required to share new information—including reimbursement amounts, ship to dates and ship to locations—as [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

SUSTAIN 340B Act On Track for Possible Early September Introduction After Last-Minute August Delay

Six bipartisan U.S. Senators could introduce a major 340B program reform bill as early as Sept. 9 following a previous delay.
A major bipartisan Senate 340B program overhaul, called the SUSTAIN 340B Act, could be released as soon as early September [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Medicaid Drug Rebate Program Summit – MDRP 2024

SPONSORED CONTENT

Experts from across the US come together each year to conquer the complex, ever-evolving Medicaid drug rebate and 340B programs and accelerate their careers by sourcing world-class content alongside everyone who matters in Medicaid. Join us in Chicago on

Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live